Treatment in heart failure and hemodialysis: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
Rim Halaby (talk | contribs) |
||
| Line 4: | Line 4: | ||
==Heart Failure and Hemodialysis== | ==Heart Failure and Hemodialysis== | ||
No recommendation was made regarding the initiation or continuation of statin therapy in 2 specific groups: | No recommendation was made regarding the initiation or continuation of statin therapy in 2 specific groups<ref name="circ.ahajournals.org">{{Cite web |last = | first = | title = 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults | url =http://circ.ahajournals.org/content/early/2013/11/11/01.cir.0000437738.63853.7a.full.pdf+html |publisher = | date = | accessdate = 13 November 2013 }}</ref>''': | ||
# Individuals with NYHA class II–IV heart failure | # Individuals with NYHA class II–IV heart failure | ||
# Individuals undergoing maintenance hemodialysis. | # Individuals undergoing maintenance hemodialysis. | ||
==References== | ==References== | ||
Revision as of 22:11, 13 November 2013
Template:Hypercholesterolemia Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Heart Failure and Hemodialysis
No recommendation was made regarding the initiation or continuation of statin therapy in 2 specific groups[1]:
- Individuals with NYHA class II–IV heart failure
- Individuals undergoing maintenance hemodialysis.
References
- ↑ "2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults". Retrieved 13 November 2013.